e-learning
resources
Vienna 2003
Monday 29.09.2003
New developments in lung transplantation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
IL-8 in BAL-fluid of lung transplant patients: a possible predictive factor for upcoming acute rejection?
B. Vanaudenaerde, W. Wuyts, L. Dupont, D. Van Raemdonck, M. Demedts, G. Verleden (Leuven, Belgium)
Source:
Annual Congress 2003 - New developments in lung transplantation
Session:
New developments in lung transplantation
Session type:
Thematic Poster Session
Number:
2074
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Vanaudenaerde, W. Wuyts, L. Dupont, D. Van Raemdonck, M. Demedts, G. Verleden (Leuven, Belgium). IL-8 in BAL-fluid of lung transplant patients: a possible predictive factor for upcoming acute rejection?. Eur Respir J 2003; 22: Suppl. 45, 2074
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma.
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Lung transplantation
Related content which might interest you:
The role of interleukin-17 during acute rejection after lung transplantation
Source: Eur Respir J 2006; 27: 779-787
Year: 2006
Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005
Hepatocyte growth factor (HGF) in lung allografts
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005
Basiliximab induction reduces the incidence of acute rejection in lung transplant patients
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Increased recipient VEGF serum level is a risk factor for severe reperfusion edema after lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 706s
Year: 2005
Acute exacerbation in patients with bronchiectasis: What prognostic factors?
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Pleural fluid cytokines after lung transplantation as markers of acute rejection development
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010
Is CRP really valid acute-phase inflammation reactant in all patients with sputum bacterial positive culture in acute exacerbation of COPD?
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Candida
colonization in lung cancer patients and its role as a prognostic factor for infection occurrence during hospitalization
Source: Eur Respir J 2003; 22: Suppl. 45, 433s
Year: 2003
Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010
Prognostic factors in patients with end stage idiopathic pulmonary fibrosis awaiting lung transplantation
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009
Frequency of interferon-gamma (IFN-γ) producing lymphocytes in BAL of lung transplanted patients with acute rejection (AR)
Source: Eur Respir J 2001; 18: Suppl. 33, 297s
Year: 2001
II-17 upregulation in BAL-fluid during acute rejection after lung transplantation: a 3 months follow-up
Source: Eur Respir J 2004; 24: Suppl. 48, 180s
Year: 2004
Sputum VEGF level increases with treatment of COPD acute exacerbation
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
The murine orthotopic single lung transplantation model for chronic rejection: work in progress?
Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction
Year: 2018
Rapid decline in lung disease other than COPD: when should lung transplantation be considered?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007
IL-6 and IL-8 in stable and exacerbated IPF patients and their association to outcome
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
TNFα-308 polymorphism associates with acute lung allograft rejection
Source: Eur Respir J 2005; 26: Suppl. 49, 175s
Year: 2005
Extracorporeal photoapheresis in the treatment of chronic lung rejection: preliminary clinical and immunological results on a small cohort of lung recipients
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept